These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21084750)

  • 21. Naive CD4+ T cells confer idiotype-specific tumor resistance in the absence of antibodies.
    Bogen B; Munthe L; Sollien A; Hofgaard P; Omholt H; Dagnaes F; Dembic Z; Lauritzsen GF
    Eur J Immunol; 1995 Nov; 25(11):3079-86. PubMed ID: 7489746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fully functional HLA B27-restricted CD4+ as well as CD8+ T cell responses in TCR transgenic mice.
    Roddis M; Carter RW; Sun MY; Weissensteiner T; McMichael AJ; Bowness P; Bodmer HC
    J Immunol; 2004 Jan; 172(1):155-61. PubMed ID: 14688321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes.
    Tsuji T; Yasukawa M; Matsuzaki J; Ohkuri T; Chamoto K; Wakita D; Azuma T; Niiya H; Miyoshi H; Kuzushima K; Oka Y; Sugiyama H; Ikeda H; Nishimura T
    Blood; 2005 Jul; 106(2):470-6. PubMed ID: 15790789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rare population of tumor antigen-specific CD4
    Matsuzaki J; Tsuji T; Chodon T; Ryan C; Koya RC; Odunsi K
    J Immunother Cancer; 2019 Jan; 7(1):7. PubMed ID: 30626427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
    Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
    Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse.
    Herbelin A; Gombert JM; Lepault F; Bach JF; Chatenoud L
    J Immunol; 1998 Sep; 161(5):2620-8. PubMed ID: 9725264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy of established tumors using bone marrow transplantation with antigen gene--modified hematopoietic stem cells.
    Cui Y; Kelleher E; Straley E; Fuchs E; Gorski K; Levitsky H; Borrello I; Civin CI; Schoenberger SP; Cheng L; Pardoll DM; Whartenby KA
    Nat Med; 2003 Jul; 9(7):952-8. PubMed ID: 12778137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-avidity autoreactive CD4+ T cells induce host CTL, overcome T(regs) and mediate tumor destruction.
    Brandmaier AG; Leitner WW; Ha SP; Sidney J; Restifo NP; Touloukian CE
    J Immunother; 2009 Sep; 32(7):677-88. PubMed ID: 19561540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR.
    Soto CM; Stone JD; Chervin AS; Engels B; Schreiber H; Roy EJ; Kranz DM
    Cancer Immunol Immunother; 2013 Feb; 62(2):359-69. PubMed ID: 22926060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells.
    Kitchen SG; Levin BR; Bristol G; Rezek V; Kim S; Aguilera-Sandoval C; Balamurugan A; Yang OO; Zack JA
    PLoS Pathog; 2012; 8(4):e1002649. PubMed ID: 22511873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell receptor gene therapy targeting melanoma-associated antigen-A4 by silencing of endogenous TCR inhibits tumor growth in mice and human.
    Sun Q; Zhang X; Wang L; Gao X; Xiong Y; Liu L; Wei F; Yang L; Ren X
    Cell Death Dis; 2019 Jun; 10(7):475. PubMed ID: 31209257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Despite efficient intrathymic negative selection of host-reactive T cells, autoimmune disease may develop in porcine thymus-grafted athymic mice: evidence for failure of regulatory mechanisms suppressing autoimmunity.
    Zhao Y; Rodriguez-Barbosa JI; Shimizu A; Sachs DH; Sykes M
    Transplantation; 2003 Jun; 75(11):1832-40. PubMed ID: 12811242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.
    Tsuji T; Yoneda A; Matsuzaki J; Miliotto A; Ryan C; Koya RC; Odunsi K
    Cancer Immunol Res; 2018 May; 6(5):594-604. PubMed ID: 29588318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice.
    Gebe JA; Unrath KA; Yue BB; Miyake T; Falk BA; Nepom GT
    J Autoimmun; 2008 Jun; 30(4):197-206. PubMed ID: 17949947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
    Dahan R; Gebe JA; Preisinger A; James EA; Tendler M; Nepom GT; Reiter Y
    J Autoimmun; 2013 Dec; 47():83-93. PubMed ID: 24090977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-DPB1*05: 01-restricted WT1332-specific TCR-transduced CD4+ T lymphocytes display a helper activity for WT1-specific CTL induction and a cytotoxicity against leukemia cells.
    Lin Y; Fujiki F; Katsuhara A; Oka Y; Tsuboi A; Aoyama N; Tanii S; Nakajima H; Tatsumi N; Morimoto S; Tamanaka T; Tachino S; Hosen N; Nishida S; Oji Y; Kumanogoh A; Sugiyama H
    J Immunother; 2013 Apr; 36(3):159-70. PubMed ID: 23502763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4.
    Nalawade SA; Ji N; Raphael I; Pratt A; Kraig E; Forsthuber TG
    Cell Immunol; 2018 Sep; 331():38-48. PubMed ID: 29789121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR.
    Cohen CJ; Zheng Z; Bray R; Zhao Y; Sherman LA; Rosenberg SA; Morgan RA
    J Immunol; 2005 Nov; 175(9):5799-808. PubMed ID: 16237072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Avidity characterization of genetically engineered T-cells with novel and established approaches.
    Hillerdal V; Boura VF; Björkelund H; Andersson K; Essand M
    BMC Immunol; 2016 Jul; 17(1):23. PubMed ID: 27411667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.